Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 04/25/16 | SC 13D | Form SC 13D: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities | 24 | |
| 04/21/16 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 1 | |
| 04/21/16 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 1 | |
| 04/21/16 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 1 | |
| 04/21/16 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 1 | |
| 04/21/16 | 8-K | Form 8-K: Current report filing | 8 | |
| 04/18/16 | CERTNAS | Form CERTNAS: Certification by the NASDAQ Stock Exchange approving securities for listing | 1 | |
| 04/18/16 | 424B4 | Form 424B4: Prospectus filed pursuant to Rule 424(b)(4) | 56 | |
| 04/18/16 | 8-A12B | Form 8-A12B: Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) | 3 | |
| 04/14/16 | EFFECT | Form EFFECT: Notice of Effectiveness | 1 |